mTOR Pathway Activation Drives Lung Cell Senescence and Emphysema

JCI insight - United States
doi 10.1172/jci.insight.93203
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

American Society for Clinical Investigation

Related search

Gephyrin Suppresses Lung Squamous Cell Carcinoma Development by Reducing mTOR Pathway Activation

Cancer Management and Research
Oncology
2019English

Aberrant mTOR Activation in Senescence and Aging: A Mitochondrial Stress Response?

Experimental Gerontology
AgingGeneticsCell BiologyMolecular BiologyBiochemistryEndocrinology
2015English

8-Chloroadenosine Sensitivity in Renal Cell Carcinoma Is Associated With AMPK Activation and mTOR Pathway Inhibition

PLoS ONE
Multidisciplinary
2015English

Lung Cellular Senescence Is Independent of Aging in a Mouse Model of COPD/emphysema

Scientific Reports
Multidisciplinary
2018English

Oncogenic Activation of Stat3 Pathway Drives Pd-L1 Expression in Natural Killer/T Cell Lymphoma

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

Targeting AXL and mTOR Pathway Overcomes Primary and Acquired Resistance to WEE1 Inhibition in Small Cell Lung Cancer

Clinical Cancer Research
Cancer ResearchOncology
2017English

Quantitative Proteomics Profiling Reveals Activation of mTOR Pathway in Trastuzumab Resistance

Oncotarget
Oncology
2017English

The mTOR Pathway in Lung Cancer and Implications for Therapy and Biomarker Analysis

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2012English

Morphine-Induced Epidermal Growth Factor Pathway Activation in Non–Small Cell Lung Cancer

Anesthesia and Analgesia
AnesthesiologyPain Medicine
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy